• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, March 31, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Bug that causes stomach cancer could play a role in colorectal cancer

Bioengineer by Bioengineer
October 9, 2018
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

DURHAM, N.C. – A bacterium known for causing stomach cancer might also increase the risk of certain colorectal cancers, particularly among African Americans, according to a study led by Duke Cancer Institute researchers.

The finding, published online Oct. 5 in the journal Gastroenterology, describes an association between antibodies to H. pylori bacteria and an increased risk of colorectal cancers, although it does not establish the bacteria as a definitive cause; those studies are ongoing.

But in an analysis of more than 4,000 colorectal cancer cases culled from large, diverse cohort studies, the researchers found a significant correlation between colorectal cancer incidence and those who had been infected with a virulent strain of H. pylori that is especially common among African Americans.

"The link between infection and cancer is intriguing, particularly if we can eradicate it with a simple round of antibiotics," said lead author Meira Epplein, Ph.D., co-leader of Cancer Control and Population Sciences at Duke Cancer Institute. "Our study provides strong evidence that we need to pursue this research to establish a definitive cause-and-effect."

Epplein and colleagues collected data from 10 large regional and national studies, including the Southern Community Cohort Study, the Nurses Health Study, the Women's Health Initiative and the American Cancer Society's Cancer Prevention Study-II, among others.

They analyzed blood samples from more than 8,400 ethnically and regionally diverse study participants — half who went on to develop colorectal cancer and the other half with no such diagnosis.

The researchers found that H. pylori infections were equally common in both the cancer and non-cancer group, with 4 in 10 patients in both groups testing positive for exposure to the bacterium.

But stark racial differences also appeared. White patients had below average H. pylori infection rates, and Asian Americans had average rates. For black and Latino patients, however, the rates were much higher. Among African Americans, 65 percent of the non-cancer patients and 71 percent of the colorectal cancer patients had H. pylori antibodies; among Latinos, 77 percent of the non-cancer group and 74 percent of the cancer group had antibodies.

Further analysis showed that antibodies to four H. pylori proteins were most often present among the different ethnic groups with colorectal cancer. One H. pylori protein in particular, VacA, had the strongest association with increased odds of colorectal cancer among the African American patients in the study, and, specifically, high levels of antibodies to this protein were associated with colorectal cancer incidence in both African Americans and Asian Americans.

"It was surprising to find VacA antibodies increased the odds of colorectal cancer in African Americans and Asian Americans, and not in whites and Latinos," Epplein said. "This is a big question – are people harboring different bacteria based on genetic origin or heritage? This is part of what we need to figure out."

Epplein said additional studies might also determine whether antibodies to the H. pylori VacA protein could serve as a marker of colorectal cancer risk if it isn't causing the cancer directly.

###

In addition to Epplein, study authors include Julia Butt, Matthew G. Varga, William J. Blot, Lauren Teras, Kala Visvanathan, Loïc Le Marchand, Christopher Haiman, Yu Chen, Ying Bao, Howard D. Sesso, Sylvia Wassertheil-Smoller, Gloria Y.F. Ho PhD, Lesley E. Tinker, Richard M. Peek, John D. Potter, Timothy L. Cover, Laura H. Hendrix, Li-Ching Huang, Terry Hyslop, Caroline Um, Francine Grodstein, Mingyang Song, Anne Zeleniuch-Jacquotte, Sonja Berndt, Allan Hildesheim, Tim Waterboer and Michael Pawlita.

The National Cancer Institute funded the study (R01 CA190428); additional support for the cohorts is listed in the journal manuscript. The development of H. pylori serology was funded in part by the Joint Initiative for Innovation and Research of the German Helmholtz Association.

Media Contact

Sarah Avery
[email protected]
919-724-5343
@DukeHealth

http://dukehealthnews.org

Share12Tweet8Share2ShareShareShare2

Related Posts

PSMA Therapy Extends Time Before Hormone Treatment in Prostate Cancer

March 31, 2026

APR-246 Boosts Chemo Response in TP53 Mutant Cancer

March 30, 2026

Avatar Created to Advance Pediatric Brain Cancer Research

March 30, 2026

uPAR: A Promising Target for CAR T Cell Therapy in Solid Tumors

March 30, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1005 shares
    Share 397 Tweet 248
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Advancements in EV Battery Technology to Surpass Climate Change-Induced Degradation

    45 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Air Pollution Alerts Significantly Improve Public Health in Chinese Cities

Unraveling the Link Between Stress and Addiction: Insights from New Research

Dr. Roxana Mehran Appointed President of the American College of Cardiology

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.